A Bayesian dose-finding design for outcomes evaluated with uncertainty.
Matthew J SchipperYing YuanJeremy Mg TaylorRandall K Ten HakenChristina TsienTheodore S LawrencePublished in: Clinical trials (London, England) (2021)
Incorporating uncertainty in dose-limiting toxicity assessment can improve the performance of the continual reassessment method design.